| Entry |
|
|---|
| Name |
Rilmenidine (INN);
Hyperium (TN) |
|---|
| Formula |
C10H16N2O
|
|---|
| Exact mass |
180.1263
|
|---|
| Mol weight |
180.2468
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01738 Centrally-acting antiadrenergic
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihypertensive, alpha2-Adrenergic receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
C02AC Imidazoline receptor agonists
C02AC06 Rilmenidine
D08482 Rilmenidine (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01738 Centrally-acting antiadrenergic
D08482 Rilmenidine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA2
D08482 Rilmenidine (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 13
1 C1y C 24.0800 -15.6800
2 C1x C 24.7100 -14.4900
3 C1x C 23.3100 -14.4900
4 C1x C 23.5200 -21.3500
5 N2x N 24.0100 -20.0200
6 C2y C 22.8200 -19.1800
7 O2x O 21.7000 -20.0200
8 C1x C 22.1200 -21.3500
9 N1b N 22.8200 -17.7800
10 C1c C 24.0800 -17.0800
11 C1y C 25.2700 -17.7800
12 C1x C 25.9700 -18.9700
13 C1x C 26.6700 -17.7800
BOND 15
1 5 6 2
2 6 7 1
3 7 8 1
4 8 4 1
5 1 2 1
6 6 9 1
7 1 3 1
8 9 10 1
9 10 1 1
10 3 2 1
11 4 5 1
12 11 12 1
13 11 13 1
14 13 12 1
15 10 11 1
|
|---|
